<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Parvovirus B19 has been identified as the etiological agent of "<z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">fifth disease</z:e>" in childhood </plain></SENT>
<SENT sid="1" pm="."><plain>It is also a rarely reported cause of <z:hpo ids='HP_0001903'>anemia</z:hpo> in transplanted patients </plain></SENT>
<SENT sid="2" pm="."><plain>During a period of 18 months we observed four cases (2 male and 2 female; 53 +/- 4.24 years) of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> due to parvovirus B19 in kidney transplant patients </plain></SENT>
<SENT sid="3" pm="."><plain>The overall incidence of the disease was 6.3% of <z:hpo ids='HP_0000001'>all</z:hpo> our transplanted patients </plain></SENT>
<SENT sid="4" pm="."><plain>Symptoms of the disease occurred 22.5 +/- 9.75 days post-operatively </plain></SENT>
<SENT sid="5" pm="."><plain>Serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> was 1.5 +/- 0.35 mg/dl </plain></SENT>
<SENT sid="6" pm="."><plain>Hb was 6.58 +/- 0.6 g/dl </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients recovered with 15 days of high doses of commercial immunoglobulins </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that B19 <z:e sem="disease" ids="C0205882" disease_type="Disease or Syndrome" abbrv="">parvovirus infection</z:e> is probably an underestimated disease in transplant patients </plain></SENT>
<SENT sid="9" pm="."><plain>It is a first-period <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, probably donor-transmitted </plain></SENT>
<SENT sid="10" pm="."><plain>High dose immunoglobulins are an effective but costly therapy </plain></SENT>
</text></document>